CSRxP: BIDEN ADMINISTRATION TAKES IMPORTANT STEP TO PROTECT SENIORS & TAXPAYERS WITH DELAY OF REBATE RULE
HHS Pause of Misguided, Pharma-Backed Policy Will Help Refocus Attention on… Read More
HHS Pause of Misguided, Pharma-Backed Policy Will Help Refocus Attention on… Read More
New RAND Report Finds Rx Prices in U.S. Average 3.44 Times Higher Than Those… Read More
CSRxP Briefing Covers Impact of Affordability Crisis, Drug Company’s… Read More
Price Hikes Fuel Sky-High Earnings For Brand Name Giants As millions of… Read More
Clear Majority of Voters Identify Rx Drug Affordability as Top Issue and… Read More
Investigation Will Shed Light On Big Pharma’s Price Hikes During Public… Read More
Bipartisan Investigation Details How Drug Companies Work in Tandem to Hike… Read More
Unjustified Rx Price Increases Cost American Patients & Health System… Read More
Misguided Policy Published in Violation of Legally Required Process for Public… Read More
Second Major Round of Pandemic Price Increases Underscores Urgency for… Read More
Drug Companies Double Down In Second Major Round Of Pandemic Price Hikes As… Read More
Part IV: Escalating Assault on 340B Program for Providers Serving America’s… Read More